All Insights
Showing 1 - 12 of 1872
Competition, antitrust and trade
What does the Getty Images/Shutterstock decision tell business about how the CMA approaches mergers in the UK?
Competition and Markets Authority rejects Getty/Shutterstock remedies, despite focus on growth
Competition, antitrust and trade
UK government consults on major reforms to competition processes
The government's growth agenda underlies a set of sweeping and probably controversial proposals
Life Sciences and Healthcare
EU device package envisages more support for 'orphan' and breakthrough products and flexible access in crises
In-house exemptions, 'orphan grandfathering', 'sandboxes' and crisis derogations aim to balance unmet needs with safety
Life Sciences and Healthcare
Draft EU medtech revisions adjust importer and distributor roles to support supply chain resilience
Digital obligations, leaner repackaging rules and new shortage reporting tools may evolve supply chain responsibilities
Life Sciences and Healthcare
Data-driven digital health businesses challenged with balancing AI advances and tighter regulation in 2026
Hyper-personalisation, data interoperability and AI are among 2025's fast-evolving areas to continue to watch this year
Life Sciences and Healthcare
EU MDR and IVDR poised to remain main framework for medical AI in draft AI interface reforms
Lex specialis treatment, integrated notified body reviews and clarified duties are designed to limit overlapping regulation of medical AI
Advertising and marketing regulation
Marketinglaw: January 2026
Welcome to the latest edition of Marketinglaw
Energy and Energy Transition
UK heat networks face new technical standards and regulations
Government publishes Warm Homes Plan and consults on HNTAS
Life Sciences and Healthcare
EU digital by default medtech plans signal shift in submissions, product information and online sales
E-submissions, digital documentation and clarified Eudamed and UDI duties to steer medtech towards fuller digitalisation
Life Sciences and Healthcare
Planned EU medtech changes and codified Helsinki procedure support consistent qualification and classification
EU coordination, expert panel opinions and targeted down classification are proposed to harmonise risk based outcomes
Life Sciences and Healthcare
What will shape European life sciences and healthcare in 2026?
There will be comprehensive regulatory changes across the UK and EU, with streamlined approval pathways alongside heightened governance and compliance
Life Sciences and Healthcare
EU drug agency to take broader coordinating role in devices and diagnostics in latest proposal
Expert panel support, shortage coordination and combined study procedures strengthen the EMA's oversight of devices
